MedPath
HSA Approval

BISACODYL SUPPOSITORIES 5MG

SIN14002P

BISACODYL SUPPOSITORIES 5MG

BISACODYL SUPPOSITORIES 5MG

August 22, 2011

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUPPOSITORY

RECTAL

Medical Information

A06AB02

bisacodyl

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. INDUSTRIES (M) SDN. BHD.

Active Ingredients

Bisacodyl

5.0mg

Bisacodyl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BISACODYL SUPPOSITORIES 5MG - HSA Approval | MedPath